Literature DB >> 24385163

Effect of the PRO-GLY-PRO peptide on hemostasis and lipid metabolism in rats with hypercholesterolemia.

L A Andreeva1, N F Myasoedov, L A Lyapina, M E Grigor'eva, T Yu Obergan, T A Shubina.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24385163     DOI： 10.1134/S0012496613060069

Source DB:  PubMed          Journal:  Dokl Biol Sci        ISSN： 0012-4966


× No keyword cloud information.
  7 in total

Review 1.  [Comparison of anticoagulant effects of regulatory proline-containing oligopeptides. Specificity of glyprolines, semax, and selank and potential of their practical application].

Authors:  L A Liapina; V E Pastorova; T Iu Obergan; G E Samonina; I P Ashmarin; N F Miasoedov
Journal:  Izv Akad Nauk Ser Biol       Date:  2006 Mar-Apr

2.  The combined antidiabetogenic and anticoagulation effecta of tripeptide Gly-Pro-Arg as estimated in the model of persistent hyperglycemia in rats.

Authors:  N F Myasoedov; L A Andreeva; L A Lyapina; A M Ulyanov; T A Shubina; T Yu Obergan; V E Pastorova; M E Grigorieva
Journal:  Dokl Biol Sci       Date:  2011-07-05

3.  Low density lipoprotein binding to human platelets: role of charge and of specific amino acids.

Authors:  M Aviram; J G Brook; A M Lees; R S Lees
Journal:  Biochem Biophys Res Commun       Date:  1981-03-16       Impact factor: 3.575

Review 4.  Gut-liver interaction in triglyceride-rich lipoprotein metabolism.

Authors:  Changting Xiao; Joanne Hsieh; Khosrow Adeli; Gary F Lewis
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-06-21       Impact factor: 4.310

5.  Depression and anxiety symptoms affect change in exercise capacity during cardiac rehabilitation.

Authors:  Evelyne Egger; Jean-Paul Schmid; Raphaela Walker Schmid; Hugo Saner; Roland von Känel
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2008-12

6.  Relationship of indices of inflammation and thrombogenesis to arrhythmia burden in paroxysmal atrial fibrillation.

Authors:  Timothy Watson; Anita Arya; Neil Sulke; Gregory Y H Lip
Journal:  Chest       Date:  2009-10-26       Impact factor: 9.410

Review 7.  An overview of the extra-lipid effects of rosuvastatin.

Authors:  Michael S Kostapanos; Haralampos J Milionis; Moses S Elisaf
Journal:  J Cardiovasc Pharmacol Ther       Date:  2008-05-06       Impact factor: 2.457
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.